GBS-NN: Phase I started

MinervaX began a double-blind, placebo-controlled, dose-escalation, U.K. Phase I trial to evaluate 3 dose levels of GBS-NN with or without an Alhydrogel adjuvant in up to 310 healthy adult female volu...